Mission Pharmacal has acquired the assets of ProSolus Pharmaceuticals LP headquartered in Miami, FL. ProSolus offers expertise in the development and manufacture of sophisticated and transdermal drug delivery products to treat a variety of therapeutic areas.   “ProSolus is the new jewel in Mission’s crown as a manufacturing supplier,” said Pete Valko, chief operating officer of ProSolus Inc., who is adding this to his responsibilities as chief operating officer of BioComp Pharma. “To expand Mi...